Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;26(2):215.
doi: 10.5863/1551-6776-26.2.215. Epub 2021 Feb 15.

Rapid Infusion of Infliximab

Nicole A Rozette, Christina M Hellauer, James E Dice

Rapid Infusion of Infliximab

Nicole A Rozette et al. J Pediatr Pharmacol Ther. 2021.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure. The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria.

References

    1. Munsel EJ, Bryan PJ, Bindstadt BA et al. Rapid infliximab infusion in the pediatric population. J Pediatr Pharmacol Ther. 2020;25(8):705–708. - PMC - PubMed
    1. Glover C, Phuong L, Hinds R. Rapid infliximab infusions are generally well-tolerated in children with inflammatory bowel disease. J Paediatr Child Health. 2017;53(1):94–95. - PubMed
    1. Lev-Tzion R, Assa A, Yerushalmi B et al. Rapid infliximab infusion in children: a multicenter retrospective cohort study. J Pediatr Gastroenterol Nutr. 2017;65:e101–e103. - PubMed
    1. El-Matary W, Dykes DMH, Bauman L et al. Rapid infliximab infusion in children with inflammatory bowel disease: a multicenter North American experience. Inflamm Bowel Dis. 2017;23(12):2104–2108. - PMC - PubMed
    1. Rozette NA, Hellauer CM, McKee C et al. Evaluation of rapid vs standard infliximab infusions in the pediatric population. Inflamm Bowel Dis. 2018;24(9):2007–2014. - PubMed

LinkOut - more resources